IM Cannabis

IM Cannabis produces and distributes medical cannabis. Its products include products for patients and offer research and development of new genetic strains.

Oren Shuster and Rafael Gabay founded IM cannabis in Glil Yam, Tel Aviv in 2010.

IM Cannabis headquartered in Asia, operates in the Pharmaceutical, Medical, Cannabis sector. The company focuses on Pharmaceutical and has secured $3.8B in funding across 60 round(s). With a team of 251-500 employees, IM Cannabis is actively contributing to advancements in Pharmaceutical. Their latest funding round, Post-IPO Equity - IM Cannabis, raised $35.0M. Discover more about their projects, partnerships, and impact on our platform.